Gene Therapy in Treating Patients With Colon Cancer That Has Spread to the Liver

Completed · Phase 1

Conditions studied: Colorectal Cancer, Metastatic Cancer

In brief

RATIONALE: Gene therapy may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the safety of NV1020 in patients who have colon cancer that has spread to the liver and has not responded to previous chemotherapy.

Key facts

Study ID

NCT00012155

Run by

Memorial Sloan Kettering Cancer Center

Starts

2000-10-01

Expected to finish

2009-12-01

Last updated by the study team

2013-06-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.